Arrowhead Pharmaceuticals, Inc. (ARWR)
73.49
+2.96
(+4.20%)
USD |
NASDAQ |
Apr 30, 16:00
73.49
0.00 (0.00%)
After-Hours: 20:00
Arrowhead Pharmaceuticals EPS Diluted (Quarterly) : 0.219 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Sarepta Therapeutics, Inc. | -3.934 |
| Johnson & Johnson | 2.141 |
| Merck & Co., Inc. | 1.191 |
| ACADIA Pharmaceuticals, Inc. | 1.596 |
| Alnylam Pharmaceuticals, Inc. | 1.368 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 28.24M |
| Revenue (Quarterly) | 264.03M |
| Total Expenses (Quarterly) | 233.22M |
| Enterprise Value | 9.642B |
| Gross Profit Margin (Quarterly) | 97.58% |
| Profit Margin (Quarterly) | 10.70% |
| Earnings Yield | 2.09% |
| Operating Earnings Yield | 2.97% |
| Normalized Earnings Yield | 2.093 |